longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Bioeasy and others establish a new company including cell technology research and development business

Zhitong
Feb 5, 2025 at 02:26 AM

According to the Qichacha APP, recently, Bioeasy ZhiJia Biotechnology Co., Ltd. was established, with Liu Fengrong as the legal representative and a registered capital of 5 million yuan. The business scope includes: research and development of bio-based material technology; research and development of fermentation process optimization technology; promotion services for new material technology; research and application of cell technology, etc. Qichacha's equity penetration shows that the company is jointly held by Bioeasy and others

Source: Zhitong The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.

Recommended Readings

  • Sep 8, 2026 at 12:14 PMAI-era DCI: Beyond the chip, compete as a network. Is there a China play?

Related Stocks

Bioeasy

Bioeasy

SZ300942

-2.40%

HIFICHEM

HIFICHEM

SZ300758

Valiant

Valiant

SZ002643

LongbridgeAI